About Avomd
Avomd is a series-b+-stage technology company operating in Biotech & Healthcare. The company is headquartered in United States. Its most recent financing was a $10M round announced on Apr 9, 2026. Notable investors include 500 Global.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
United States
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
avomd.io
Domain Registered Date
Sep 19, 2018
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $10,000,000 · Series-A
fundraisingfox.com
- Capital Raise
Series-B+ announced
fundraisingfox.com
- Milestone
Website domain registered
avomd.io
Investors & Backers
500 Global
Funding History
Series-A
· Apr 9, 2026
$10,000,000 fundraisingfox.com
Series-B+
· Sep 29, 2021
Undisclosed fundraisingfox.com
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026